BLOG

Cue Biopharma Pioneers In Vivo T-Cell Enhancement

Cue Biopharma has quickly evolved into a player in the T-cell space. The company was formed in 2015, a spin-out from the Albert Einstein College of Medicine. Dan Passeri, the company CEO, has a background in oncology drug development and has worked at the National Cancer Institute. When he was asked to take over the firm in August 2016, he was employee number eight.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}